ED
KLAC icon

Exane Derivatives’s KLA KLAC Stock Holding History

Exane Derivatives’s Portfolio KLAC Stock Details KLAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$155K Sell
4,860
-12,440
-72% -$418K 0.09% 201
2022
Q1 		$633K Buy
17,300
+1,900
+12% +$71.1K 0.18% 154
2021
Q4 		$662K Buy
15,400
+3,550
+30% +$137K 0.16% 142
2021
Q3 		$396K Sell
11,850
-160
-1% -$5.34K 0.1% 229
2021
Q2 		$374K Sell
12,010
-6,480
-35% -$208K 0.08% 241
2021
Q1 		$611K Sell
18,490
-390
-2% -$11.8K 0.17% 126
2020
Q4 		$489K Sell
18,880
-2,580
-12% -$60.1K 0.14% 159
2020
Q3 		$416K Buy
21,460
+800
+4% +$15.8K 0.12% 153
2020
Q2 		$402K Sell
20,660
-2,740
-12% -$46.8K 0.11% 168
2020
Q1 		$336K Buy
23,400
+23,270
+17,900% +$375K 0.09% 149
2019
Q4 		$2.31K Hold
130
– – ﹤0.01% 486
2019
Q3 		$2.07K Sell
130
-1,740
-93% -$24.3K ﹤0.01% 485
2019
Q2 		$22.1K Buy
1,870
+1,640
+713% +$19K ﹤0.01% 422
2019
Q1 		$2.75K Sell
230
-382,160
-100% -$4.11M ﹤0.01% 429
2018
Q4 		$3.42M Buy
382,390
+112,920
+42% +$1.05M 0.61% 42
2018
Q3 		$2.74M Buy
269,470
+266,440
+8,793% +$2.91M 0.51% 62
2018
Q2 		$31.1K Sell
3,030
-6,930
-70% -$75.3K 0.01% 407
2018
Q1 		$107K Buy
9,960
+9,580
+2,521% +$107K 0.02% 294
2017
Q4 		$3.99K Buy
+380
New +$4.01K ﹤0.01% 436
2017
Q3 		– Sell
-202,100
Closed -$1.85M – 614
2017
Q2 		$1.85M Sell
202,100
-104,570
-34% -$1.04M 0.4% 68
2017
Q1 		$2.92M Buy
306,670
+304,510
+14,098% +$2.68M 0.66% 41
2016
Q4 		$17K Hold
2,160
– – ﹤0.01% 378
2016
Q3 		$15.1K Buy
+2,160
New +$15.5K ﹤0.01% 381

Other funds holding KLAC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Exane Derivatives's KLAC Position: Q2 2022 in Review

Exane Derivatives reduced its KLA (KLAC) stake by 72% in Q2 2022, selling an estimated $418K and leaving 4,860 shares worth $155K. The position accounts for 0.09% of the portfolio, ranked #201.

Exane Derivatives first reported a position in KLAC in Q3 2016 and has held it in 23 quarters since. The position peaked at $3.42M in Q4 2018. 1,071 funds tracked by Wall St. Rank hold KLAC as of Q2 2022.

  • Exane Derivatives held 4,860 shares of KLA worth $155K as of Q2 2022.
  • Exane Derivatives sold 12,440 KLA shares in Q2 2022, an estimated $418K.
  • KLA made up 0.09% of Exane Derivatives's portfolio in Q2 2022, its #201 holding.
  • Exane Derivatives first reported a position in KLA in Q3 2016 and has held it in 23 quarters since.
  • Exane Derivatives's KLA position peaked at $3.42M in Q4 2018.
  • 1,071 funds tracked by Wall St. Rank held KLA as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.